46 /100
MEDIUM RISK
Score updated May 30, 2026

DCOY — Decoy Therapeutics Inc. Dilution Risk Tracker

Track DCOY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DCOY — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
22
⚠️ Warrant Exposure
70
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
32%
📜 Warrant Exercise 40%
• Significant warrants: 27% of shares outstanding
• Elevated warrant risk score (70/100)
📉 Score Deterioration 40%
• Score rose 26 points recently (worsening)
🔔 Track DCOY — Get forecast alerts →

💹 Market Data

Market Cap$4.75M
Shares Outstanding532.0K
Float528.4K
Cash$7.82M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

9 institutional holders · 79.3K shares
#1 Warberg Asset Management LLC 28.0K shares
#2 StoneX Group Inc. 20.0K shares
#3 XTX Topco Ltd 10.9K shares
+ 6 more holders Sign up free to view →

📉 Short Interest

Short Interest8.5K
Days to Cover1.0
% of Float1.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2020
4 INSIDER TRANSACTION Jan 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track DCOY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DCOY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for DCOY
📊 DCOY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DCOY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.